Excessive production of interleukin 6/B cell stimulatory factor‐2 in rheumatoid arthritis

Toshio Hirano(Institut de Biologie Moléculaire et Cellulaire), Tadashi Matsuda(Institut de Biologie Moléculaire et Cellulaire), Martin Turner(Green Cross International), Nobuyuki Miyasaka, Glenn Buchan(Green Cross International), Bo Tang, Kazuto Sato, Masatoshi Shimi(Osaka Minami Medical Center), Ravinder Maid(Kennedy Center), Marc Feldmann(Green Cross International), Tadamitsu Kishimoto(Institut de Biologie Moléculaire et Cellulaire)
European Journal of Immunology
November 1, 1988
Cited by 789

Abstract

High levels of interleukin 6 (IL 6/B cell stimulatory factor-2) were detected in synovial fluids from the joints of patients with active rheumatoid arthritis (RA). The cells found in freshly isolated synovial fluid constitutively expressed IL 6 mRNA. The synovial tissues obtained by joint biopsy were also found to produce IL 6 in vitro. Immunohistochemical analysis demonstrated that CD2+ T cells as well as CD20+ blastoid B cells in the synovial tissues produce IL 6. The data indicate that IL 6 is generated constitutively in RA and its overproduction may explain the local as well as the generalized symptoms of RA, since IL 6 can function as B cell growth and differentiation factor as well as hepatocyte-stimulating factor.


Related Papers

No related papers found

Powered by citation graph analysis